top of page
Executive Spotlights

Protaryx Medical Welcomes David Mester as New CEO to Spearhead Advancements

Baltimore, MD, September 12, 2023 (Business Wire) -- Protaryx Medical, announces, David Mester, MBA, as its newly appointed Chief Executive Officer (CEO). With a remarkable career spanning more than three decades in the structural heart medical device sector, Mester is poised to infuse Protaryx with his experience. Additionally, Protaryx is delighted to introduce Peter Boyd, J.D., MBA, as the latest addition to its distinguished board of directors.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page